BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9618393)

  • 1. The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543.
    Showell HJ; Conklyn MJ; Alpert R; Hingorani GP; Wright KF; Smith MA; Stam E; Salter ED; Scampoli DN; Meltzer S; Reiter LA; Koch K; Piscopio AD; Cortina SR; Lopez-Anaya A; Pettipher ER; Milici AJ; Griffiths RJ
    J Pharmacol Exp Ther; 1998 Jun; 285(3):946-54. PubMed ID: 9618393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.
    Showell HJ; Pettipher ER; Cheng JB; Breslow R; Conklyn MJ; Farrell CA; Hingorani GP; Salter ED; Hackman BC; Wimberly DJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):176-84. PubMed ID: 7714764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the pharmacological profile of the potent LTB4 antagonist CP-105,696 on murine LTB4 receptors in vitro.
    Showell HJ; Breslow R; Conklyn MJ; Hingorani GP; Koch K
    Br J Pharmacol; 1996 Mar; 117(6):1127-32. PubMed ID: 8882606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
    Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
    J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis.
    Griffiths RJ; Pettipher ER; Koch K; Farrell CA; Breslow R; Conklyn MJ; Smith MA; Hackman BC; Wimberly DJ; Milici AJ
    Proc Natl Acad Sci U S A; 1995 Jan; 92(2):517-21. PubMed ID: 7831322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity.
    Sarau HM; Foley JJ; Schmidt DB; Martin LD; Webb EF; Tzimas MN; Breton JJ; Chabot-Fletcher M; Underwood DC; Hay DW; Kingsbury WD; Chambers PA; Pendrak I; Jakas DR; Sathe GM; Van Horn S; Daines RA; Griswold DE
    Prostaglandins Leukot Essent Fatty Acids; 1999 Jul; 61(1):55-64. PubMed ID: 10477044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profile of a novel, orally active leukotriene B4 antagonist, SM-15178.
    Ohmi N; Tani C; Yamada K; Fukui M
    Inflammation; 1994 Apr; 18(2):129-40. PubMed ID: 8070898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982.
    Jackson WT; Boyd RJ; Froelich LL; Mallett BE; Gapinski DM
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1009-14. PubMed ID: 1335049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of human neutrophil activation by 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]propoxy]phenoxy]benzoic acid (LY293111), a novel leukotriene B4 receptor antagonist.
    Marder P; Sawyer JS; Froelich LL; Mann LL; Spaethe SM
    Biochem Pharmacol; 1995 May; 49(11):1683-90. PubMed ID: 7786309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ONO-4057, a novel, orally active leukotriene B4 antagonist: effects on LTB4-induced neutrophil functions.
    Kishikawa K; Tateishi N; Maruyama T; Seo R; Toda M; Miyamoto T
    Prostaglandins; 1992 Oct; 44(4):261-75. PubMed ID: 1332129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
    Tsai BS; Keith RH; Villani-Price D; Haack RA; Djuric SW
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo effects of leukotriene B4 antagonism in a primate model of asthma.
    Turner CR; Breslow R; Conklyn MJ; Andresen CJ; Patterson DK; Lopez-Anaya A; Owens B; Lee P; Watson JW; Showell HJ
    J Clin Invest; 1996 Jan; 97(2):381-7. PubMed ID: 8567958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SC-41930: an inhibitor of leukotriene B4-stimulated human neutrophil functions.
    Tsai BS; Villani-Price D; Keith RH; Zemaitis JM; Bauer RF; Leonard R; Djuric SW; Shone RL
    Prostaglandins; 1989 Dec; 38(6):655-74. PubMed ID: 2561214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: impact upon leukotriene B4- and 12(R)-HETE-mediated events.
    Fretland DJ; Anglin CP; Bremer M; Isakson P; Widomski DL; Paulson SK; Docter SH; Djuric SW; Penning TD; Yu S
    Inflammation; 1995 Apr; 19(2):193-205. PubMed ID: 7601505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific inhibition of leukotriene B4 (LTB4)-induced neutrophil emigration by 20-hydroxy LTB4: implications for the regulation of inflammatory responses.
    Pettipher ER; Salter ED; Breslow R; Raycroft L; Showell HJ
    Br J Pharmacol; 1993 Sep; 110(1):423-7. PubMed ID: 8220903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro pharmacology of SC-51146: a potent antagonist of leukotriene B4 receptors.
    Tsai BS; Keith RH; Villani-Price D; Kachur JF; Yang DC; Djuric SW; Yu S
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1499-505. PubMed ID: 8138960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification on receptors for leukotriene B4 expressed on guinea-pig peritoneal eosinophils.
    Sehmi R; Rossi AG; Kay AB; Cromwell O
    Immunology; 1992 Sep; 77(1):129-35. PubMed ID: 1328044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils.
    Sperling RI; Benincaso AI; Knoell CT; Larkin JK; Austen KF; Robinson DR
    J Clin Invest; 1993 Feb; 91(2):651-60. PubMed ID: 8381824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of in vivo desensitization to leukotriene B4 on eosinophil infiltration in response to C5a in guinea-pig skin.
    Pettipher ER; Salter ED; Showell HJ
    Br J Pharmacol; 1994 Sep; 113(1):117-20. PubMed ID: 7812600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukotriene B4 mediates substance P-induced granulocyte infiltration into mouse skin. Comparison with antigen-induced granulocyte infiltration.
    Iwamoto I; Tomoe S; Tomioka H; Yoshida S
    J Immunol; 1993 Aug; 151(4):2116-23. PubMed ID: 7688393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.